Shuttle Pharmaceuticals Holdings (SHPH) Non-cash Items (2022 - 2023)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Non-cash Items of $231550.0 in Q4 2023, up 278.9% quarter-over-quarter from $61111.0 in Q4 2022, and up 278.9% on a YoY basis from $61111.0 in Q4 2022.
Shuttle Pharmaceuticals Holdings (SHPH) Non-cash Items (2022 - 2023) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Non-cash Items history runs 2 years deep, the most recent figure standing at $231550.0 for Q4 2023.
- In Q4 2023, Non-cash Items rose 278.9% year-over-year to $231550.0; the TTM figure through Dec 2023 stood at $231550.0 (up 278.9% YoY), while the FY2023 annual figure was $231550.0, up 278.9% from the prior year.
- Non-cash Items was $231550.0 for Q4 2023 at Shuttle Pharmaceuticals Holdings, up from $61111.0 in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $231550.0 in Q4 2023 to a low of $58813.0 in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 231,550.00 |
| Dec 31, 2023 | 231,550.00 |
| Dec 31, 2022 | 61,111.00 |
| Dec 31, 2022 | 61,111.00 |
| Sep 30, 2022 | 58,813.00 |
| Sep 30, 2022 | 58,813.00 |